Loading…
Makes specialty ingredients: choline nutrients for animal feed, encapsulated nutrients for food, and performance/industrial chemicals.
Makes specialty ingredients: choline nutrients for animal feed, encapsulated nutrients for food, and performance/industrial chemicals.
Sells ingredients that customers blend into feed, foods and supplements, including choline protected to survive a cow's stomach, which helps dairy herd health. An ethylene oxide unit sells sterilisation gas and other specialty chemicals to healthcare and industrial users. Growth is helped by buying small niche ingredient companies.
Moat: narrow (IP / patents, process know-how, customer qualification). Encapsulation and specialty-chemical process know-how create qualification barriers for niche nutrient markets.
Headquarters: New Hampton, New York, US · Founded: 1967 · Employees: 1,352
Size Balchem (BCPC) is a United States Consumer Staples company (Food: Specialty/Candy) with a market value of $5.54B, the 1111th largest of 3,117 United States companies the cockpit tracks. Shares closed at $174.43 on 6 Nov 2026.
Performance Over six months the shares gained 8.4%, against +1.2% for the median peer and -1.1% for the United States market (cap-weighted) — 9th highest of 21 in its peer set.
Growth Revenue grew 9.4% over the last twelve months (peer median +8.2%); the operating margin is 21.5% (peer median 9.6%).
Valuation It trades at 30.9× forward earnings against a peer median of 15.9× (most expensive of 21).
Price implies For today's price to make sense, revenue must grow about 14% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is +6 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 4.5 points above its cost of capital (9.0% WACC).
Short interest Short interest is 1.6% of the free float (15 Oct 2026).
Next results Next results expected around 19 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $1.11B | $1.04B | $954M | $922M | $942M |
| Revenue growth | — | +9% | +3% | -2% | — |
| Gross profit | $404M | $371M | $336M | $302M | $280M |
| EBITDA | $287M | $264M | $232M | $233M | $199M |
| Net income | $171M | $155M | $128M | $109M | $105M |
| Free cash flow | $178M | $173M | $146M | $146M | $88.2M |
| Capital expenditure | $45.8M | $43.5M | $35.7M | $37.9M | $50.3M |
| Total debt | $142M | $181M | $208M | $330M | $461M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Balchem BCPC | $5.54B | +8% | +9% | 22% | 30.9× | 14.5% |
| Archer Daniels Midland ADM | $33.3B | -9% | +1% | 3% | 12.0× | 8.0% |
| DSM-Firmenich DSFIR.AS | $29.5B | +62% | -45% | 8% | 30.1× | 24.3% |
| International Flavors & Fragrances IFF | $20.7B | +2% | -17% | 11% | 23.4× | 17.9% |
| Phibro Animal Health PAHC | $1.34B | -18% | +17% | 13% | 9.1× | -7.4% |
| Bluestar Adisseo 600299.SS | $3.97B | -35% | +15% | 13% | 11.8× | -8.6% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | BCPC | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +3.4% | +8.0% | 9th lowest of 21 |
| 6-month return | +8.4% | +1.2% | 9th highest of 21 |
| Distance from 52-week high | -6.3% | -18.2% | 3rd highest of 21 |
| Revenue growth (TTM) | +9.4% | +8.2% | 10th highest of 21 |
| Operating margin | 21.5% | 9.6% | highest of 21 |
| Forward P/E | 30.9× | 15.9× | most expensive of 21 |
| Growth the price implies (Req g, 7 yrs) | 14.5% | -2.5% | 2nd most demanding of 17 |
| Growth delivered (Del g) | +8.1% | +10.0% | 6th lowest of 17 |
| Hurdle (Req g minus delivered) | +6.4 pp | -9.0 pp | 3rd most demanding of 17 |
| ROIC minus cost of capital | +4.5 pp | +2.3 pp | 7th highest of 21 |
| EV / EBITDA | 19.6× | 9.7× | 2nd most expensive of 18 |
| Net debt / EBITDA | 0.3× | 2.4× | 5th least indebted of 18 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Balchem BCPC | United States | $5.54B | +8% | +9% | 22% | 30.9× | 14.5% | +8.1% |
| Nissin Foods 2897.T | Japan | $5.73B | +9% | +5% | 6% | 17.9× | n/a | n/a |
| Ingredion INGR | United States | $5.78B | -15% | -1% | 12% | 9.7× | -7.8% | +3.8% |
| Yamazaki Baking 2212.T | Japan | $5.08B | +21% | +5% | 5% | 18.0× | -3.3% | +5.3% |
| Sensient Technologies SXT | United States | $5.07B | +1% | +10% | 15% | 25.0× | n/a | n/a |
| Angel Yeast 600298.SS | China | $4.97B | +2% | +15% | 11% | 19.1× | 4.1% | +13.4% |
| Aak AAK.ST | Sweden | $4.88B | -30% | -1% | 10% | 13.6× | -6.0% | +10.5% |
| Toyo Suisan Kaisha 2875.T | Japan | $6.74B | -4% | +7% | 17% | 14.5× | -5.0% | +9.5% |
| Campbell's CPB | United States | $6.90B | +11% | -5% | 11% | 13.7× | -3.6% | +2.8% |
| Meiji 2269.T | Japan | $7.35B | +14% | +4% | 8% | 17.2× | n/a | n/a |
| Lamb Weston LW | United States | $7.61B | +31% | +3% | 10% | 16.6× | 4.0% | +12.5% |
| Darling Ingredients DAR | United States | $7.92B | -20% | +16% | 9% | 7.3× | 9.0% | +11.4% |
| Anjoy Foods 2648.HK | Hong Kong | $3.83B | -20% | +24% | 12% | 11.6× | -2.9% | +17.5% |
| Barry Callebaut BARN.SW | Switzerland | $8.33B | +5% | +9% | 5% | 23.7× | -8.4% | +16.5% |
| Post POST | United States | $3.65B | -19% | +6% | 10% | 11.8× | -2.1% | +7.4% |
| Vita Coco COCO | United States | $3.56B | -13% | +26% | 20% | 30.2× | 8.4% | +14.4% |
| Ashland ASH | United States | $3.51B | +39% | +2% | 7% | 18.0× | 12.3% | -2.5% |
| Jinan Shengquan Group Share 605589.SS | China | $3.46B | -30% | +12% | 8% | 19.7× | n/a | n/a |
| Orion 271560.KS | South Korea | $3.45B | -18% | +11% | 17% | 9.9× | -17.1% | +8.4% |
| Tate & Lyle TATE.L | United Kingdom | $3.34B | +53% | +16% | 9% | 15.2× | 10.8% | +10.6% |
| Greencore GNC.L | United Kingdom | $3.23B | +31% | +26% | 6% | 14.3× | 22.4% | +9.0% |